Urinary Incontinence. Biopolymer GmbH & Co.KG - Germany
|
|
- Lee Cummings
- 5 years ago
- Views:
Transcription
1 Urinary Incontinence
2 Treatment Options: 1. Physical Therapy: a conservative early stage treatment for UI, including pelvic floor muscles training known as Kegel exercise. 2. Medications: by means of pharmaceutical drugs ( fesoterodine, tolterodine, oxybutynin,..etc ). 3. devices: absorbent pads, urinary catheters. 4. Surgical procedures. 5. Bulking agents Urethral Injections of impant material.
3 Treatment Options: Surgical procedures: 1. TVT: Tension-Free transvaginal sling. 2. TOT: Transoburator tape sling. 3. Mini Sling ( mini-arc ) ( TVT-secure) 4. Marshal-Marchetti-Krantz: retropubic suspension / bladder neck suspension 5. Artificial unrinary sphincter.
4 Treatment Options: Urethral Injections Bulking Agents: Is a minimal surgical procedure providing An alternative in treatment options: The Ideal Bulking agent of choice must include following charecteristics: 1. Biocompatible. 2. Biodegradable. 3. Bio-stable: no deformation after injection. 4. No Migration after implantion. 5. No erosion after implantion. 6. Easy to applicate without the need to apply pressure when injecting.
5 Treatment Options: Available Bulking Agents for UI: 1. Polytetrafluoroethylene(teflon) : no longer used. 2. Autologous fat: no longer used. 3. Macroplastique: silicone elastomer polydimethylsiloxane suspended in polyvinylpyrrolidone PVP Carrier. It is a permanent implant applied by transurethral technique injection beneath the lining of urethra can cause urethral erosion with irreversable damage in case of failure of procedure procedure must be done in operation room. 4. Contigen: Glutar aldehyde cross linked bovine collagen: it begins degradation within 12 weeks with complete degaradation within 19month, and patient must undergo a skin test to exclude hypersinsensitivity due to collagen ( animal origin ) before one month of the procedure.
6 Treatment Options: Available Bulking Agents: 5. Bulkamid: 25% polyacrylamide hydrogel, 97% apyrogenic water, is a permanent implant (nonbiodegradable) 6. Durasphere: carbon coated zirconium oxide particles suspended in water soluble B-glucan vehicle, is a permanent implant, upon clinical trials Durasphere migrates from impantation site which might cause permanent urinary retention. 7. Coaptite: calcium hydroxylapatite particles suspended in sodium carboxymethylcellulose, water, glycerin gel form carrier, upon clinical trials the particles becomes deformed, irregular along with migration from injection site resulting in periurethral fibrosis, obstruction, prolapse.
7 Treatment Options: Available Bulking Agents: 8. Tegress: formrly known as URYX : ethylenevinyl alcohol copolymer suspended in dimethyl sulfoxide: have discontinued sales due to reports of 37% erosion rates. 9. Zuidex: Dextranomere microspheres in cross linked hyaluronic acid carrier. 10.Urodex : DEAE-Sephadex- Dextran positively Charged Dextranomere. Urodex composition: Sodium Hyaluronate cross linked: 17mg DEAE Sephadex Dextran + chagre: 50mg Sodium Chloride: 6.9mg Water for injection: 1.0ml
8 Urodex designed Technolgy: Why to use Urodex? What is the added Benefits of Urodex? In order to realize the added benefits of Urodex, a summary explaining the designation technology of the product will answer many questions that may arise. 1. In SUI and as the condition is resulting from pelvic floor muscles weakness that leads to insufficient closure of urethra, basically a material that acts as a bulking agent is needed in order to act in increased tissue thickness at injection site that will aid in complete closure when muscles plays its normal role. and accordingly, the material of choice was DEAE-DEXTRAN ( Diethylaminoethyl- Dextran), the choice was based upon that Dextran is a Biocompatible, Biodegradable, non-immunogenic molecule. Dextran: consists of linked glucan with side chains attached to the 3-position of the backbone glucose units, and it is produced by bacterial fermentation process ( nonanimal origin ).
9 Urodex designed Technolgy: 2. DEAE-Dextran Biomaterial cannot be introduced by injection And as the concept of the products is based upon minimal Surgical procedure a carrier material is needed to carry the DEAE-DEXTRAN to site of implantation, the choice of carrier material was the specially designed cross linked hyaluronic acid Technically adjusted to play the role of a ( carrier ), again the choice was upon that HA is a biocompatible, biodegradable, Non-immunogenic molecule. 3. After that and as a long duration effect is favorable in treatment of SUI the Specially designed cross linking process was applied to DEAE-DEXTRAN to obtain a cross Linked DEAE-DEXTRANOMERE or what is called a DEAE-Sephadex-Dextran, Sephadex Is a trade mark for cross linked dextran, where cross linking process results in a long term Duration of the implant to be degraded gradually.
10 Urodex designed Technolgy: 4. Finally, a ( fine tuning ) process was created by Biopolymer GmbH Germany to ensure maximum effect results outcome for the product ( Urodex ) to be unique and distinguished in SUI Treatment options, the ( fine tuning ) was made by creating a positive charge on DEAE-Sephadex Dextran which stimulates collagen formation in site of implantation and leading by that for optimum results in treatment of SUI by stimulating tissue regeneration process. Accordingly, DEAE-Sephadex-Dextran is a polycationic cross linked dextran with tissue regeneration stimulating effect. 5. Accordingly, the benefits of Urodex are summarized as following: A. Biocompatible: as the used materials is a natural component of human body tissues, it is non-immunogenic ( non-animal origin ), and biocompatibility is optimal due to formation of fibroblast and collagen fibers that surrounds the microparticles. B. Biodegradable: the used materials are completely degradable with safe clinical profile. C. Long action duration: due to cross linking process that extends up to 5 five years. D. No Migration from implant site: due to positively charged microparticles the positive charge plays a role in ( ancoring ) the implant through inter-cellular interactions leading to fibroblasts and collagen fibers surrounding the implant material as well that microparticles size used ensures no migration. ( safe particel size 80 micron ). E. Stimulation of collagen formation: due to positive charges.
11 Urodex Kit: Urodex Kit: 4 syringes 1.0ml 2 sterile needles 20G 1 Applicator 1 catheter
12 Urodex Applicator Special design for minimal invasive and safe implantation Controlled implantation in a 4-position (3, 6, 9, 12) symmetrical placement with injection volume of 1.0ml per position. Periurethral Injection technique.
13 Urodex Applicator Designed with measurements for implantation in precise site. After measurement of urethra by catheter, transfer the length to the applicator, insert the applicator into urethra to the previosuly marked measurement and inject the implant material. Video is available for procedure.
14 URODEX Injection Introduce mounted needle in the applicator Important! Opening of the needle in direction upward
15 The Implantation 1 syringe/1 ml in position 3
16 The Implantation 1 syringe/1 ml in position 9
17 The Implantation 1 syringe/1 ml in position 12
18 The Implantation 1 syringe/1 ml in position 6
19 Clinical trials
20 Thank you
MEDICAL POLICY SUBJECT: BULKING AGENTS FOR TREATMENT OF URINARY OR FECAL INCONTINENCE. POLICY NUMBER: CATEGORY: Technology Assessment
MEDICAL POLICY SUBJECT: BULKING AGENTS FOR (ARCHIVED DATE: 05/28/09-, EDITED DATE: 05/27/10, 05/19/11, 05/24/12, 05/23/13) PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific
More informationPeriurethral Bulking Agents for the Treatment of Urinary Incontinence. Original Policy Date
MP 7.01.14 Periurethral Bulking Agents for the Treatment of Urinary Incontinence Medical Policy Section Surgery Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature
More informationCorporate Medical Policy
Corporate Medical Policy Injectable Bulking Agents for the Treatment of Urinary and Fecal File Name: Origination: Last CAP Review: Next CAP Review: Last Review: injectable_bulking_agents_for_the_treatment_of_urinary_and_fecal_incontinence
More informationMedical Policy Title: Periurethral Bulking ARBenefits Approval: <Date>
Medical Policy Title: Periurethral Bulking ARBenefits Approval: Agents for the Treatment of Incontinence Effective Date: 01/01/2012 Document: ARB0279 Revision Date: Code(s): 51715 Endoscopic injection
More informationTitle: Zuidex versus Contigen for Stress Urinary Incontinence. Date: May 30, 2007
Title: Zuidex versus Contigen for Stress Urinary Incontinence Date: May 30, 2007 Context and policy issues: Stress urinary incontinence (SUI) is the involuntary leakage of urine during exercise or movements
More informationInterventional procedures guidance Published: 12 October 2016 nice.org.uk/guidance/ipg566
Single-incision short sling mesh insertion for stress urinary incontinence in women Interventional procedures guidance Published: 12 October 2016 nice.org.uk/guidance/ipg566 Your responsibility This guidance
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Injectable Bulking Agents for the Page 1 of 18 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: See Also: Injectable Bulking Agents for the Treatment of Urinary and
More informationSubject: Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
09-A9000-03 Original Effective Date: 02/15/12 Reviewed: 12/06/18 Revised: 12/15/18 Subject: Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence THIS MEDICAL COVERAGE GUIDELINE
More informationBlue Ridge Urogynecology
Surgery for Stress Urinary Incontinence Surgery has proved to be a very effective treatment for stress incontinence. The best surgical procedures improve or cure the incontinence in 85 to 90 percent of
More informationq7:480499_P0 6/5/09 10:23 AM Page 1 WHAT YOU SHOULD KNOW ABOUT YOUR DIAGNOSIS OF STRESS URINARY INCONTINENCE
493495.q7:480499_P0 6/5/09 10:23 AM Page 1 WHAT YOU SHOULD KNOW ABOUT YOUR DIAGNOSIS OF STRESS URINARY INCONTINENCE 493495.q7:480499_P0 6/5/09 10:23 AM Page 2 What is Stress Urinary Incontinence? Urinary
More informationMedical Review Criteria Invasive Treatment for Urinary Incontinence
Medical Review Criteria Invasive Treatment for Urinary Incontinence Effective Date: December 21, 2016 Subject: Invasive Treatment for Urinary Incontinence Background: Urinary incontinence (the involuntary
More informationSep \8958 Appell Dmochowski.ppt LMF 1
Surgical Outcomes (How did we get ourselves into this mess?) Roger R. Dmochowski, MD, FACS Department of Urologic Surgery Vanderbilt University School of Medicine Nashville, Tennessee Considerations Evaluation
More informationMP Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
Medical Policy MP 7.01.19 BCBSA Ref. Policy: 7.01.19 Last Review: 08/20/2018 Effective Date: 08/20/2018 Section: Surgery Related Policies 1.01.17 Pelvic Floor Stimulation as a Treatment of Urinary and
More informationMedical Coverage Policy Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
Medical Coverage Policy Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence EFFECTIVE DATE:02 5 2013 POLICY LAST UPDATED: 12 18 2018 OVERVIEW Bulking agents are injectable substances
More informationFecal Incontinence. Sphincter Augmentation. Alaiyan Bilal MD Hadassah mt scopus
Fecal Incontinence Sphincter Augmentation Alaiyan Bilal MD Hadassah mt scopus AUGMENTATION METHODS Injectables( Bulking agents) Radiofrequency INJECTABLES Biomaterials Polytef, Autologous fat, GAX (glutaraldehyde
More informationInjectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence Policy Number: 7.01.19 Last Review: 6/2014 Origination: 2/1994 Next Review: 6/2015 Policy Blue Cross and Blue Shield of Kansas
More informationA minimally invasive treatment for stress urinary incontinence
A minimally invasive treatment for stress urinary incontinence This booklet provides information about the Bulkamid hydrogel for the treatment of stress urinary incontinence What is stress urinary incontinence?
More informationInjectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence Policy Number: 7.01.19 Last Review: 6/2017 Origination: 2/1994 Next Review: 6/2018 Policy Blue Cross and Blue Shield of Kansas
More informationINJECTABLE BULKING AGENTS FOR THE TREATMENT OF URINARY AND FECAL INCONTINENCE
FECAL INCONTINENCE Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
More informationOperative Approach to Stress Incontinence. Goals of presentation. Preoperative evaluation: Urodynamic Testing? Michelle Y. Morrill, M.D.
Operative Approach to Stress Incontinence Goals of presentation Michelle Y. Morrill, M.D. Director of Urogynecology The Permanente Medical Group Kaiser, San Francisco Review preoperative care & evaluation
More informationW17: Intrinsic Sphincteric Deficiency, Diagnosis and Management Workshop Chair: Sherif Mourad, Egypt 20 October :00-18:00
W7: Intrinsic Sphincteric Deficiency, Diagnosis and Management Workshop Chair: Sherif Mourad, Egypt 20 October 204 4:00-8:00 Start End Topic Speakers 4:00 4:05 Introduction Sherif Mourad 4:05 4:20 Pathophysiology
More informationInjectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
7.01.19 Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence Section 7.0 Surgery Subsection Effective Date February 27, 2015 Original Policy Date February 27, 2015 Next Review
More informationPost- prostatectomy Incontinence - PPI
Post- prostatectomy Incontinence - PPI Dr. Kolombo Ivan, MD, FEBU Assoc.Prof. Popken Gralf MD, PhD, Assoc.Prof. Otčenášek Michal MD, PhD, Dr. Klézl Petr MD, MBA, Dr. Kolombová Jitka MD, MBA, Assoc.Prof.
More informationProtocol. Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
Injectable Bulking Agents for the Treatment of Urinary and Fecal (70119) Medical Benefit Effective Date: 07/01/15 Next Review Date: 05/18 Preauthorization No Review Dates: 01/08, 11/08, 09/09, 09/10, 09/11,
More informationClinical Policy: Urinary Incontinence Devices and Treatments
Clinical Policy: Reference Number: CP.MP.142 Last Review Date: 03/18 See Important Reminder at the end of this policy for important regulatory and legal information. Coding Implications Revision Log Description
More informationName of Policy: Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
Name of Policy: Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence Policy #: 455 Latest Review Date: July 2014 Category: Surgery Policy Grade: B Background/Definitions: As a
More informationI-STOP TOMS Transobturator Male Sling
I-STOP TOMS Transobturator Male Sling The CL Medical I-STOP TOMS sling for male stress urinary incontinence was developed in France where it is widely used and is the market leader. It is constructed with
More informationInjectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
Last Review Status/Date: September 2015 Page: 1 of 16 Urinary and Fecal Incontinence Description Bulking agents are injectable substances that used to increase tissue bulk. They can be injected periurethrally
More informationTHE BULKING AGENT WITH LONG-LASTING EFFECT!
THE BULKING AGENT WITH LONG-LASTING EFFECT! Urogyn BV Transistorweg 5a 6534 AT Nijmegen The Netherlands t +31(0) 24 711 41 30 info@urogynbv.com www.urogynbv.com THE FIRST INJECTABLE IMPLANT THAT CAN COMPETE
More informationMACROPLASTIQUE IMPLANTS
UROPLASTY, INC. MACROPLASTIQUE IMPLANTS INSTRUCTIONS FOR USE UROPLASTY, INC. MACROPLASTIQUE IMPLANTS INSTRUCTIONS FOR USE CONTRAINDICATIONS FOR USE Macroplastique must not be used in patients with: Acute
More informationMP Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
Medical Policy MP 7.01.19 BCBSA Ref. Policy: 7.01.19 Last Review: 08/30/2017 Effective Date: 08/30/2017 Section: Surgery End Date: 08/19/2018 Related Policies 1.01.17 Pelvic Floor Stimulation as a Treatment
More informationInjectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
Last Review Status/Date: March 2017 Page: 1 of 16 Urinary and Fecal Incontinence Description Bulking agents are injectable substances used to increase tissue bulk. They can be injected periurethrally to
More informationProlapse & Stress Incontinence
Advanced Pelvic Floor Course Prolapse & Stress Incontinence OVERVIEW Day One and morning of Day Two- Pelvic Organ Prolapse The Prolapse component covers the detailed anatomy of POP including the DeLancey
More informationA PATIENT GUIDE TO Understanding Stress Urinary Incontinence
A PATIENT GUIDE TO Understanding Stress Urinary Incontinence Q: What is SUI? A: Stress urinary incontinence is defined as the involuntary leakage of urine. The problem afflicts approximately 18 million
More informationSurgery for stress incontinence:
Surgery for stress incontinence: information for you aashara Published February 2005 by the RCOG Contents Key points About this information What is stress incontinence? Do I need an operation? What operation
More informationComparison of Autologous, Non-autologous, and Synthetic Periurethral Bulking Agents
Comparison of Autologous, Non-autologous, and Synthetic Periurethral Bulking Agents Abstract Andrew J. Steward Department of Aerospace and Mechanical Engineering University of Notre Dame, Notre Dame, IN
More informationRECENT ADVANCES IN THE MANAGEMENT OF URINARY INCONTINENCE
RECENT ADVANCES IN THE MANAGEMENT OF URINARY INCONTINENCE SAAD JUMA, MD INCONTINENCE RESEARCH INSTITUTE ENCINITAS, CA AUA STRESS URINARY INCONTINENCE GUIDELINE UPDATE INDEX PATIENTS The otherwise healthy
More informationNew Insights in the Surgical Management of Stress Urinary Incontinence in Women
New Insights in the Surgical Management of Stress Urinary Incontinence in Women Gabriel Gillon MD Dept. of Urology Rabin Med. Cent. /Beilinson Incontinence and LUTS 25/6/2009 Symposium Ramat Aviv New Insights
More informationTHE LONG-TERM SOLUTION FOR MALE INCONTINENCE
THE LONG-TERM SOLUTION FOR MALE INCONTINENCE Urogyn BV Transistorweg 5a 6534 AT Nijmegen The Netherlands t +31(0) 24 711 41 30 info@urogynbv.com www.urogynbv.com THE FIRST INJECTABLE IMPLANT THAT CAN COMPETE
More informationManagement of Post-Prostatectomy Urinary Incontinence and Sexual Dysfunction
Management of Post-Prostatectomy Urinary Incontinence and Sexual Dysfunction Robert C. Eyre, MD, FACS Associate Clinical Professor of Surgery (Urology) Harvard Medical School Post-prostatectomy Incontinence
More informationThis information is intended as an overview only
This information is intended as an overview only Please refer to the INSTRUCTIONS FOR USE included with this device for indications, contraindications, warnings, precautions and other important information
More informationOne Slim Needle One Incision. One Simple Solution for Stress Urinary Incontinence. The Difference is in the Data
CONTINENCE SOLUTIONS One Slim Needle One Incision ordering information Description US International Order Number Order Number One Simple Solution for Stress Urinary Incontinence MiniArc Single-Incision
More informationWhat you should know about your diagnosis of incontinence
What you should know about your diagnosis of incontinence What is Stress Urinary Incontinence? WHAT IS NORMAL URINARY FUNCTION? Urine is a normal waste product of the body that is manufactured by the kidneys
More informationContributor contact details
Contributor contact details Preface Fundamentals p. 1 Introduction to biofilms in urology p. 3 Introduction p. 3 What is a biofilm and why do they form? p. 4 Biofilm formation and structure p. 5 p. xv
More informationManagement of recurrent stress urinary incontinence and urinary retention following midurethral sling insertion in women
UROLOGY doi 10.1308/003588412X13373405385610 Management of recurrent stress urinary incontinence and urinary retention following midurethral sling H Hashim 1, TR Terry 2 1 North Bristol NHS Trust, UK 2
More information6 Page Male Incontinence Booklet 10/09/ :44 Page 1. The Natural Non-Surgical Option for Male Urinary Incontinence
6 Page Male Incontinence Booklet /9/ :44 Page The Natural Non-Surgical Option for Male Urinary Incontinence 6 Page Male Incontinence Booklet /9/ :44 Page Stress Urinary Incontinence - A Stressful Prospect
More information*Please see amendment for Pennsylvania Medicaid at the end
1 of 90 Number: 0223 (Replaces CPBs 283, 324, and 470) Policy *Please see amendment for Pennsylvania Medicaid at the end of this CPB. I. Aetna considers multi channel urodynamic studies medically necessary
More informationFDA & Transvaginal Mesh: What Happened? What s Next?
FDA & Transvaginal Mesh: What Happened? What s Next? Matthew D. Barber, MD MHS Professor & Vice Chair for Clinical Research Obstetrics Gynecology & Women s Health Institute Disclosures I receive no grants,
More informationUrinary Incontinence Treatment URINARY INCONTINENCE TREATMENT HS-080. Policy Number: HS-080. Original Effective Date: 2/2/2009
Easy Choice Health Plan, Inc. Exactus Pharmacy Solutions, Inc. Harmony Health Plan, Inc. Missouri Care, Incorporated WellCare Health Insurance of Arizona, Inc., operating in Hawai i as Ohana Health Plan,
More informationCorporate Medical Policy
Corporate Medical Policy Vesicoureteral Reflux, Treatment with Periureteral Bulking Agents File Name: Origination: Last CAP Review: Next CAP Review: Last Review: vesicoureteral_reflux_treatment_with_periureteral_bulking_agents
More informationPolyacrylamide Hydrogel (Bulkamid ) in Female Patients of 80 or More Years with Urinary Incontinence
ORIGINAL ARTICLE Vol. 40 (1): 37-43 January - February, 2014 doi: 10.1590/S1677-5538.IBJU.2014.01.06 Polyacrylamide Hydrogel (Bulkamid ) in Female Patients of 80 or More Years with Urinary Incontinence
More informationCurrent trend in anti-incontinence surgery
Current trend in anti-incontinence surgery 吳銘斌醫師 (Ming-Ping Wu, M.D., Ph.D.) 奇美醫院婦產部婦女泌尿暨骨盆醫學科主任台北醫學大學醫學院婦產學科副教授成功大學醫學院臨床醫學所博士 Anti-incontinence surgery Bladder buttress operation: Kelly plication Needle
More informationUrinary Incontinence. Lora Keeling and Byron Neale
Urinary Incontinence Lora Keeling and Byron Neale Not life threatening. Introduction But can have a huge impact on quality of life. Two main types of urinary incontinence (UI). Stress UI leakage on effort,
More informationDesara TV and Desara Blue TV
Desara TV and Desara Blue TV Sling for Female Stress Urinary Incontinence Instructions For Use D I Prescription Use only Do not reuse Sterilized using ethylene oxide Available Electronically M Manufactured
More informationAus Artificial Uretheral Sphincter Port System
NORFOLK VET PRODUCTS the AUS for the long-term relief of incontinence in dogs and cats making life easier for pets Speciality Medical Devices For The Veterinary Community the Aus Artificial Uretheral Sphincter
More informationPeriurethral bulking injections for stress urinary incontinence
n The Leeds Teaching Hospitals NHS Trust Periurethral bulking injections for stress urinary incontinence Information for patients Leeds Centre for Women s Health Urinary incontinence is the involuntary
More informationStress Incontinence. Susannah Elvy Urogynaecology CNS
Stress Incontinence Susannah Elvy Urogynaecology CNS Definitions Prevalence Assessment Investigation Treatment Surgery Men International Continence Society define as the complaint of any involuntary leakage
More informationUrethrolysis; When, Why & How. M Karram Professor of Ob/Gyn & Urology University of Cincinnati
Urethrolysis; When, Why & How M Karram Professor of Ob/Gyn & Urology University of Cincinnati Anatomy Urethra may be fixed to the pubic bone with dense scar tissue Goal of urethrolysis is to completely
More informationMedical Policy Title: Radiofrequency ARBenefits Approval: 10/19/2011
Medical Policy Title: Radiofrequency ARBenefits Approval: 10/19/2011 Treatment, Urinary Stress Incontinence, Transurethral Effective Date: 01/01/2012 Document: ARB0359 Revision Date: Code(s): 53860 Transurethral
More informationNATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Urinary incontinence: the management of urinary incontinence in women
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Urinary incontinence: the management of urinary incontinence in women 1.1 Short title Urinary incontinence 2 Background a) The National
More informationGamal Ghoniem,*, Jacques Corcos, Craig Comiter, Peter Bernhard, O. Lenaine Westney and Sender Herschorn
Cross-Linked Polydimethylsiloxane Injection for Female Stress Urinary Incontinence: Results of a Multicenter, Randomized, Controlled, Single-Blind Study Gamal Ghoniem,*, Jacques Corcos, Craig Comiter,
More informationURINARY INCONTINENCE
Center for Continence Care and Pelvic Medicine What is urinary incontinence? URINARY INCONTINENCE Urinary incontinence is the uncontrollable loss of urine. The amount of urine leaked can vary from only
More informationCATRIX WOUND DRESSING CARTILAGE POWDER
CATRIX WOUND DRESSING CARTILAGE POWDER Distributed By: Lescarden Inc. NY, NY (USA) Customer Relations: Toll Free (USA) (888) 581-2076. (212) 687-1050 Internet: www.catrix.com E-mail: info@catrix.com CATRIX
More informationManagement of Female Stress Incontinence
Management of Female Stress Incontinence Dr. Arvind Goyal Associate Professor (Urology& Renal Transplant) Dayanand Medical College & Hospital, Ludhiana, Punjab, India Stress Incontinence Involuntary loss
More informationAdvanced Care for Female Overactive Bladder & Urinary Incontinence. Department of Urology Kaiser Permanente Santa Rosa
Advanced Care for Female Overactive Bladder & Urinary Incontinence Department of Urology Kaiser Permanente Santa Rosa Goals Participants will: Review normal urinary tract anatomy and function Understand
More informationMP A Prospective Evaluation of the Catheter Science M3 Mini Catheter for Patients with Prostatic Obstruction. Gaines W. Hammond Jr.
MP73-06 - A Prospective Evaluation of the Catheter Science M3 Mini Catheter for Patients with Prostatic Obstruction Gaines W. Hammond Jr. MD FACS M3 Mini Catheter M3 Segmented M3 Plus Dynamic Wings M3
More informationInternational Federation of Gynecology and Obstetrics
International Federation of Gynecology and Obstetrics COMMITTEE FOR UROGYNAECOLOGY AND PELVIC FLOOR MEMBER: TSUNG-HSIEN (CHARLES) SU, CHAIR (TAIWAN) DAVID RICHMOND, CO-CHAIR (UK) CHITTARANJAN PURANDARE,
More informationPelvic Prolapse. A Patient Guide to Pelvic Floor Reconstruction
Pelvic Prolapse A Patient Guide to Pelvic Floor Reconstruction Pelvic Prolapse When an organ becomes displaced, or slips down in the body, it is referred to as a prolapse. Your physician has diagnosed
More informationVarious Types. Ralph Boling, DO, FACOG
Various Types Ralph Boling, DO, FACOG The goal of this lecture is to increase assessment and treatment abilities for physicians managing urinary incontinence (UI) patients. 1. Effectively communicate with
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Urinary incontinence in women: the management of urinary incontinence in women 1.1 Short title Urinary incontinence in women
More informationFemale Urinary Incontinence: What It Is and What You Can Do About It
Female Urinary Incontinence: What It Is and What You Can Do About It Urogynecology Patient Information Sheet What is Urinary Incontinence? Stress Incontinence is a leakage of urine that occurs, for example,
More informationUP DATE MANAGEMENT OF URINARY INCONTINENCE IN ADULT
UP DATE MANAGEMENT OF URINARY INCONTINENCE IN ADULT Yunizaf, MD Division of Urogynecology Department of Obstetrics and Gynecology School of Medicine, University of Indonesia/ Dr. Cipto Mangunkusumo Hospital
More informationMedical Policy. Description/Scope. Position Statement
Subject: Document #: Current Effective Date: 03/29/2017 Status: Revised Last Review Date: 02/02/2017 Description/Scope This document addresses the following treatments for urinary incontinence: Vaginal
More informationInjection of Urethral Bulking Agents
Injection of Urethral Bulking Agents Department of Gynaecology Patient Information What are urethral bulking agents? Urethral bulking agents are substances that are injected to support the bladder neck.
More informationIncontinence; Lets talk about it. Karanvir Virk M.D. Minimally Invasive and Pelvic Reconstructive Surgery
Incontinence; Lets talk about it Karanvir Virk M.D. Minimally Invasive and Pelvic Reconstructive Surgery Select the most appropriate subtitle for this talk A: Bladders gone wild! B: There s no such thing
More informationTension Free vaginal tape. Mrs Ami Shukla, Consultant Urogynaecologist Northampton General Hospital Northampton NN1 5BD
Tension Free vaginal tape Mrs Ami Shukla, Consultant Urogynaecologist Northampton General Hospital Northampton NN1 5BD What is a TVT procedure? A TVT (Tension Free Vaginal Tape) procedure is an operation
More informationBladder neck bulking injection. Information for patients Gynaecology
Bladder neck bulking injection Information for patients Gynaecology What is a bladder neck bulking agent? It is a treatment option for stress urinary incontinence in women. What are the benefits of this
More informationSurgical treatment of urinary stress incontinence with tension free vaginal tape
Surgical treatment of urinary stress incontinence with tension free vaginal tape Gynaecology department 01935 384 385 yeovilhospital.nhs.uk Many surgical operations are available for the treatment of
More informationScottish Clinical Coding Standards
Scottish Clinical Coding Standards Number 16 October 2017 Scottish Clinical Coding Standards ICD-10 Sepsis Sepsis is a serious condition which must always be coded when documented in the medical record.
More informationThe Safety and Efficacy of a New Adjustable Single Incision Sling for Treatment of Female. Stress Urinary Incontinence Through 12-months of Follow-up
Manuscript (Submit in MS Word; include Title Page and Abstract; Tables and Figures should NOT be included but attached separately) Runninghead: ALTIS SINGLE INCISION SLING The Safety and Efficacy of a
More informationCigna Medical Coverage Policy
Cigna Medical Coverage Policy Subject Injectable Bulking Agents for Urinary Conditions and Fecal Incontinence Table of Contents Coverage Policy... 1 General Background... 2 Coding/Billing Information...
More information1) What conditions is vaginal mesh used to commonly treat? Vaginal mesh is used to treat two different health issues in women:
Vaginal Mesh Frequently Asked Questions 1) What conditions is vaginal mesh used to commonly treat? Vaginal mesh is used to treat two different health issues in women: a) stress urinary incontinence (SUI)
More informationStress Urinary Incontinence in Women. What YOU can do about it...
Stress Urinary Incontinence in Women What YOU can do about it... www.gynecare.com Stress Urinary Incontinence in Women: It's Common. It's Treatable. Would it surprise you... To learn that more than 13
More informationAn Open, Multicentre Study of NASHA/Dx Gel (Zuidex TM ) for thetreatment of Stress Urinary Incontinence
European Urology European Urology 48 (2005) 488 494 Female UrologyöIncontinence An Open, Multicentre Study of NASHA/Dx Gel (Zuidex TM ) for thetreatment of Stress Urinary Incontinence Christopher R. Chapple
More informationBSUG Annual scientific update 5/6 th Nov 2012
BSUG Annual scientific update 5/6 th Nov 2012 Zainab Khan SWIG 4/12/2012 New developments in drug therapy B3 Agonists: Mirabegron - FDA approval - Mirabegron (50 &100mg) vs tolterodine 4mg- similar efficacy,
More informationJohn Laughlin 4 th year Cardiff University Medical Student
John Laughlin 4 th year Cardiff University Medical Student Prolapse/incontinence You need to know: Pelvic floor anatomy in relation to uterovaginal support and continence The classification of uterovaginal
More informationBard: Continence Therapy. Stress Urinary Incontinence. Regaining Control. Restoring Your Lifestyle.
Bard: Continence Therapy Stress Urinary Incontinence Regaining Control. Restoring Your Lifestyle. Stress Urinary Incontinence Urinary incontinence is a common problem and one that can be resolved by working
More informationEfficacy and Safety of the TVT-SECUR R and Impact on Quality of Life in Women with Stress Urinary Incontinence: A 2-Year Follow-Up
www.kjurology.org DOI:10.4111/kju.2011.52.5.335 Voiding Dysfunction Efficacy and Safety of the TVT-SECUR R and Impact on Quality of Life in Women with Stress Urinary Incontinence: A 2-Year Follow-Up Yu
More informationLoss of Bladder Control
BLADDER HEALTH: Surgery for Urinary Incontinence Loss of Bladder Control Surgery for Urinary Incontinence Don t Let Urinary Incontinence Keep You from Enjoying Life. What is Urinary Incontinence? What
More informationWhat the radiologists should know about US and MR findings of female urinary incontinence surgical tapes.
What the radiologists should know about US and MR findings of female urinary incontinence surgical tapes. Poster No.: C-0744 Congress: ECR 2017 Type: Educational Exhibit Authors: T. Robba, L. Squintone,
More informationInformation from the MAUDE Database
Information from the MAUDE Database Device mesh, surgical, polymeric Regulation Description Surgical mesh. Product Code FTL Regulation Number 878.3300 Device Class 2 Manufacturer ETHICON Medical Device
More informationINSTRUCTIONS FOR USE FOR:
INSTRUCTIONS FOR USE FOR: en English INSTRUCTIONS FOR USE GORE ENFORM PREPERITONEAL BIOMATERIAL Carefully read all instructions prior to use. Observe all instructions, warnings, and precautions noted throughout.
More informationINCONTINENCE AND OTHER UROLOGICAL DILEMMAS DR. ANNA LAWRENCE UROLOGIST AUCKLAND HOSPITAL 161 UROLOGY
INCONTINENCE AND OTHER UROLOGICAL DILEMMAS DR. ANNA LAWRENCE UROLOGIST AUCKLAND HOSPITAL 161 UROLOGY COVERING INCONTINENCE BE ON JUST NAPPIES CATHETERS TYPES AVAILABLE AND WHEN TO USE THEM JJ STENTS???
More informationHydrophilic Coating - Living tissue interaction
Tailoring polymer friction, wear and hydrophilic lubricity of intermittent catheters Page 1 Content Introduction to hydrophilic coating technology Development and applications of hydrophilic coatings on
More informationA.M.I. ATOMS System. Hydraulic system substitutes urinary sphincter function in incontinent males
A.M.I. ATOMS System Product Group Urology Issue 11/2016 ATOMS = Adjustable TransObturator Male System Hydraulic system substitutes urinary sphincter function in incontinent males Long-term, adjustable
More informationLoss of Bladder Control
BLADDER HEALTH Loss of Bladder Control SURGERY TO TREAT URINARY INCONTINENCE AUA FOUNDATION OFFICIAL FOUNDATION OF THE AMERICAN UROLOGICAL ASSOCIATION What Is Urinary Incontinence? Urinary incontinence
More informationIncontinence. Anatomy The human body has two kidneys. The kidneys continuously filter the blood and make urine.
Incontinence Introduction Urinary incontinence occurs when a person cannot control the emptying of his or her urinary bladder. It can happen to anyone, but is very common in older people. Urinary incontinence
More informationDesara and Desara Blue
Desara and Desara Blue Sling for Female Stress Urinary Incontinence Instructions For Use D I Prescription Use only Do not reuse Sterilized using ethylene oxide M Manufactured by: Caldera Medical, Inc.
More informationPelvic Health Coding & Payment Quick Reference
Payer policies will vary and should be verified prior to treatment for limitations on diagnosis, coding or site of service requirements. The coding options listed within this guide are commonly used codes
More information